JP2022529466A5 - - Google Patents
Info
- Publication number
- JP2022529466A5 JP2022529466A5 JP2021561813A JP2021561813A JP2022529466A5 JP 2022529466 A5 JP2022529466 A5 JP 2022529466A5 JP 2021561813 A JP2021561813 A JP 2021561813A JP 2021561813 A JP2021561813 A JP 2021561813A JP 2022529466 A5 JP2022529466 A5 JP 2022529466A5
- Authority
- JP
- Japan
- Prior art keywords
- optionally substituted
- unsubstituted
- alkyl
- compound according
- formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962835301P | 2019-04-17 | 2019-04-17 | |
| US62/835,301 | 2019-04-17 | ||
| PCT/US2020/028349 WO2020214728A1 (en) | 2019-04-17 | 2020-04-15 | Bicyclic and tricyclic compounds |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022529466A JP2022529466A (ja) | 2022-06-22 |
| JP2022529466A5 true JP2022529466A5 (enExample) | 2023-04-24 |
| JP7381602B2 JP7381602B2 (ja) | 2023-11-15 |
Family
ID=72838352
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021561813A Active JP7381602B2 (ja) | 2019-04-17 | 2020-04-15 | 二環式及び三環式化合物 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US11591341B2 (enExample) |
| EP (1) | EP3956331A4 (enExample) |
| JP (1) | JP7381602B2 (enExample) |
| KR (1) | KR102641566B1 (enExample) |
| CN (1) | CN113939513A (enExample) |
| AU (1) | AU2020260105A1 (enExample) |
| CA (1) | CA3136603A1 (enExample) |
| TW (1) | TWI819213B (enExample) |
| WO (1) | WO2020214728A1 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3195542A1 (en) | 2020-10-15 | 2022-04-21 | Aligos Therapeutics, Inc. | Bicyclic compounds |
| CN114478536B (zh) * | 2020-10-28 | 2024-12-13 | 上海森辉医药有限公司 | 四氢吡嗪稠环衍生物的制备方法 |
| CN118201942A (zh) | 2021-09-08 | 2024-06-14 | 阿利戈斯治疗公司 | 经修饰的短干扰核酸(siNA)分子和其用途 |
| EP4511374A4 (en) | 2022-04-20 | 2026-04-08 | Aligos Therapeutics Inc | BICYCLE COMPOUNDS |
| WO2024228401A1 (ja) * | 2023-05-02 | 2024-11-07 | 国立大学法人 大分大学 | 新型コロナウイルス感染症の処置または予防用医薬としての置換三環式複素環化合物 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2660261A1 (en) * | 2006-08-09 | 2008-02-14 | Pfizer Products Inc. | Heterocycles useful as inhibitors of carbonic anhydrase |
| MA41338B1 (fr) * | 2015-01-16 | 2019-07-31 | Hoffmann La Roche | Composés de pyrazine pour le traitement de maladies infectieuses |
| WO2016168633A1 (en) * | 2015-04-17 | 2016-10-20 | Abbvie Inc. | Indazolones as modulators of tnf signaling |
| US10179131B2 (en) | 2015-07-13 | 2019-01-15 | Enanta Pharmaceuticals, Inc. | Hepatitis B antiviral agents |
| CN110066278B (zh) * | 2017-06-01 | 2021-06-08 | 广东东阳光药业有限公司 | 稠合三环类化合物及其在药物中的应用 |
| MX2021005357A (es) | 2018-11-08 | 2021-06-30 | Aligos Therapeutics Inc | Polimeros oligonucleotidos que inhiben el transporte de antigeno s y metodos. |
| CA3195542A1 (en) | 2020-10-15 | 2022-04-21 | Aligos Therapeutics, Inc. | Bicyclic compounds |
-
2020
- 2020-04-15 US US16/849,851 patent/US11591341B2/en active Active
- 2020-04-15 KR KR1020217037462A patent/KR102641566B1/ko active Active
- 2020-04-15 CA CA3136603A patent/CA3136603A1/en active Pending
- 2020-04-15 JP JP2021561813A patent/JP7381602B2/ja active Active
- 2020-04-15 CN CN202080040122.7A patent/CN113939513A/zh active Pending
- 2020-04-15 AU AU2020260105A patent/AU2020260105A1/en not_active Abandoned
- 2020-04-15 WO PCT/US2020/028349 patent/WO2020214728A1/en not_active Ceased
- 2020-04-15 EP EP20791559.6A patent/EP3956331A4/en not_active Withdrawn
- 2020-04-16 TW TW109112853A patent/TWI819213B/zh active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2015526448A5 (enExample) | ||
| ES2773138T3 (es) | Derivados de 3-(2-aminopirimidin-4-il)-5-(3-hidroxipropinil)-1H-pirrolo[2,3-c]piridina como inhibidores de NIK para el tratamiento del cáncer | |
| JP2022501430A5 (enExample) | ||
| JP2010514768A5 (enExample) | ||
| JP2019055954A (ja) | 化学療法の間の正常細胞の一時的な保護 | |
| JP2022534501A5 (enExample) | ||
| JP2018533611A5 (enExample) | ||
| KR20230028486A (ko) | 1'-시아노 뉴클레오시드 유사체 및 이의 용도 | |
| JP2023520916A5 (enExample) | ||
| JP2020505396A5 (enExample) | ||
| AU2014352404A1 (en) | Dihydropyrimidine compounds and their application in pharmaceuticals | |
| WO2018013597A4 (en) | 2,5-disubstituted 3-methyl pyrazines and 2,5,6-trisubstituted 3-methyl pyrazines as allosteric shp2 inhibitors | |
| JP2022522486A5 (enExample) | ||
| RU2350605C2 (ru) | Аналоги хиназолина в качестве ингибиторов рецепторных тирозинкиназ | |
| BR112016018633B1 (pt) | Pirazolopirimidina-5,7-diaminas como inibidores de cdk, seus usos, composição farmacêutica e seu método de preparação, e método in vitro para inibir a função de quinase dependente de ciclina em uma célula | |
| RU2009105826A (ru) | 2,4-ди(ариламино)питимидин-5-карбоксамидные соединения в качестве ингибиторов jak-киназ | |
| RU2017145650A (ru) | Ингибиторы тирозинкиназы брутона | |
| RU2018127728A (ru) | Слитые трициклические гетероциклические соединения в качестве ингибиторов интегразы вич | |
| JP2021534108A5 (enExample) | ||
| CN116323630A (zh) | 磷脂化合物及其用途 | |
| RU2017118165A (ru) | Ингибиторы энхансера гомолога 2 zestes | |
| JP2021501756A5 (enExample) | ||
| IL295975A (en) | Inhibitors of receptor interacting protein kinase i for the treatment of disease | |
| JP2022537140A5 (enExample) | ||
| WO2019222238A2 (en) | Substituted 2,2'-bipyrimidinyl compounds, analogues thereof, and methods using same |